Teladoc Q1: BetterHelp Weakness Persists, Insurance Pivot Shows Early Progress

What happened

Teladoc's Q1 2026 revenue fell 2% YoY to $613.8M, missing earnings expectations as BetterHelp revenue dropped 9% on a 9% decline in paying users. International growth and cost cuts helped narrow the net loss YoY, but Integrated Care's 2% growth was partly acquisition-driven, masking organic member declines. The insurance-covered services pivot at BetterHelp showed early progress with $12.9M in revenue and an annualized run-rate above $75M, targeting $125M by year-end. However, the core thesis hinges on whether this insurance scaling can offset cash-pay erosion without compressing margins, as warned in the 10-K. With FY26 free cash flow guidance of $130M-$170M and $750.7M cash, the stock at $6.10 prices in continued decline, making observable milestones in the next two quarters critical.

Implication

If insurance scaling meets targets and Integrated Care utilization lifts, the stock offers asymmetric upside with FCF yield >10%; otherwise, risk of impairment and further downside.

Thesis delta

The Q1 report confirms a two-speed model: Integrated Care stable but member declines, BetterHelp weak but insurance pivot nascent. The key shift is that insurance-covered services revenue is now measurable ($12.9M), providing a tangible catalyst to monitor. If this accelerates, the bear case of continued decline may be challenged; if it stalls, the stock remains range-bound or worse.